The below resolutions were passed at
Election of the board of directors and auditor
The AGM resolved, in accordance with the proposal from the nomination committee, that the number of board members appointed by the shareholders' meeting shall be ten.
Fees to board members and auditor
The AGM resolved that the fees to the board members shall be paid out in a total amount of
Adoption of the annual accounts, allocation of the results and discharge from liability
The AGM resolved to adopt the annual accounts for the company and the group for 2022. In accordance with the proposal from the board of directors, the AGM determined that dividend of
Remuneration report
The AGM approved the remuneration report prepared by the board of directors.
Instructions to the nomination committee
The AGM adopted the nomination committee's proposed instructions to the nomination committee.
Guidelines for remuneration to senior executives
The AGM adopted the board of directors' proposed guidelines for remuneration to senior executives.
Long term performance-based share program
The AGM resolved, in accordance with the proposal from the board of directors, to adopt a long term performance-based share program for group management and other key individuals within the
Authorisation for the board of directors to resolve to issue new shares
The AGM authorised, in accordance with the proposal from the board of directors, the board of directors to, at one or several occasions and for the period until the next annual general meeting, resolve to issue new Class B shares. The purpose is to increase the financial flexibility of the company and the acting scope of the board of directors. The authorisation allows the board of directors to resolve to increase the company's share capital by issue of new shares at one or several occasions and for the time period until the end of the next annual general meeting, with or without deviation from the shareholders' preferential rights and with or without provisions for contribution in kind, set-off or other conditions, to the extent that it corresponds to a dilution of not more than ten per cent of the number of shares outstanding at the time of the shareholders' meeting's resolution on the proposed authorisation.
Authorisation for the board of directors to resolve to repurchase own shares
The AGM authorised, in accordance with the proposal from the board of directors, the board of directors to resolve upon repurchases of own shares of class B, on one or several occasions prior to the annual general meeting 2024. The purpose of the authorisation is to promote efficient capital usage in the company and to provide flexibility as regards the company's possibilities to distribute capital to its shareholders. Repurchase shall maximum comprise so many shares of class B that the company's holding does not at any time exceed ten per cent of the total number of shares in the company. Repurchase may only take place on Nasdaq Stockholm and only at a price within the price range applicable at any given time, i.e. the range between the highest purchase price and the lowest selling price.
The underlying proposals to the above resolutions are published, and at the latest on
For further information, please contact:
+46 703 033 272
hanna.bjellquist@medicover.com
https://news.cision.com/medicover/r/bulletin-from-annual-general-meeting-in-medicover-ab--publ-,c3759469
https://mb.cision.com/Main/15662/3759469/2018591.pdf
(c) 2023 Cision. All rights reserved., source